News und Analysen
Calian Group Q2 Earnings Call Highlights
Calian Group (TSE:CGY) reported record second-quarter revenue and sharply higher adjusted EBITDA, with management pointing to accelerating demand in defense and space markets, improved execution
Stereotaxis Q1 Earnings Call Highlights
Stereotaxis (NYSEAMERICAN:STXS) said its first-quarter results did not yet reflect what management described as a major commercial transition
Pelthos Therapeutics Q1 Earnings Call Highlights
Pelthos Therapeutics (NYSEAMERICAN:PTHS) reported higher first-quarter revenue as prescriptions for its lead product, ZELSUVMI, continued to grow in the treatment’s third full quarter since launch
NeoVolta Q3 Earnings Call Highlights
NeoVolta (NASDAQ:NEOV) reported third-quarter fiscal 2026 revenue of approximately $2 million, roughly in line with the year-earlier period, while management emphasized progress on its transition
ImmuCell Q1 Earnings Call Highlights
ImmuCell (NASDAQ:ICCC) reported a record first quarter of 2026, with management saying the company’s narrowed focus on its First Defense calf scours prevention portfolio helped drive its first-ever
EQS-HV: Heidelberg Pharma AG: Bekanntmachung der Einberufung zur Hauptversammlung am 23.06.2026 in Ladenburg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
Nova Q1 Earnings Call Highlights
Nova (NASDAQ:NVMI) reported record first-quarter 2026 revenue and profitability, with management citing strong demand from advanced
Dr. Reddy's Laboratories Q4 Earnings Call Highlights
Dr. Reddy's Laboratories (NYSE:RDY) reported what Chief Financial Officer M.V. Narasimham described as a resilient FY 2026
Arrowhead Pharmaceuticals Eyes $4B REDEMPLO Opportunity as RNAi Pipeline Readouts Near
Arrowhead Pharmaceuticals (NASDAQ:ARWR) is moving into a more commercial phase while continuing to expand its RNA interference pipeline
Rapid Micro Biosystems Q1 Earnings Call Highlights
Rapid Micro Biosystems (NASDAQ:RPID) reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook, citing momentum in system placements, consumables and recurring revenue, while
Aeluma Q3 Earnings Call Highlights
Aeluma (NASDAQ:ALMU) executives said the company is seeing increased customer interest in its photonics technology as artificial intelligence
ClearPoint Neuro Q1 Earnings Call Highlights
ClearPoint Neuro (NASDAQ:CLPT) reported record first-quarter 2026 revenue and reaffirmed its full-year outlook, as management highlighted growth in its legacy neurosurgical device business and
Lumexa Imaging Q1 Earnings Call Highlights
Lumexa Imaging (NASDAQ:LMRI) reported first-quarter results that management said were in line with expectations, as growth in advanced imaging modalities helped offset seasonal volume pressure and
Novanta Q1 Earnings Call Highlights
Novanta (NASDAQ:NOVT) reported stronger-than-expected first-quarter 2026 results, with management citing broad-based bookings growth, accelerating demand in automation and medical markets, and
Mettler-Toledo International Q1 Earnings Call Highlights
Mettler-Toledo International (NYSE:MTD) reported first-quarter 2026 sales growth and higher adjusted earnings, with
Cannae Q1 Earnings Call Highlights
Cannae (NYSE:CNNE) said it returned the bulk of its first-quarter capital allocation to shareholders while continuing to evaluate sales of non-core holdings and emphasizing growth in its
AST SpaceMobile Q1 Earnings Call Highlights
AST SpaceMobile (NASDAQ:ASTS) said it remains on track with its 2026 deployment and revenue plans as the satellite-to-smartphone
Lumen Technologies Q1 Earnings Call Highlights
Lumen Technologies (NYSE:LUMN) said first-quarter 2026 results were in line with its expectations as management
Eastman Kodak Q1 Earnings Call Highlights
Eastman Kodak (NYSE:KODK) reported higher first-quarter revenue and operational EBITDA for 2026, with management pointing to growth in its print and
BlackSky Technology Q1 Earnings Call Highlights
BlackSky Technology (NYSE:BKSY) raised its 2026 revenue and adjusted EBITDA outlook after reporting first-quarter results that management said
Pulse Biosciences Q1 Earnings Call Highlights
Pulse Biosciences (NASDAQ:PLSE) said it is sharpening its focus on its nanosecond pulsed field ablation platform for atrial fibrillation after reporting first-quarter 2026 results and highlighting
ALX Oncology Q1 Earnings Call Highlights
ALX Oncology (NASDAQ:ALXO) executives used the company’s first-quarter 2026 earnings call to highlight new clinical data for its lead CD47 blocker, evorpacept, and to provide updates on its
nLight Q1 Earnings Call Highlights
nLight (NASDAQ:LASR) reported what management called an “exceptional” first quarter of 2026, with revenue, margins, and profitability coming in
Kulicke and Soffa Industries Q2 Earnings Call Highlights
Kulicke and Soffa Industries (NASDAQ:KLIC) reported fiscal second-quarter 2026 results that management said reflected faster-than-expected
Q1 2026 Telecom Wars: Analyst Eye 30% Gains in T-Mobile Post-Earnings
AT&T (NYSE: T), Verizon Communications (NYSE: VZ), and T-Mobile US (NASDAQ: TMUS) are the three dominant players in the United States telecom industry. These firms battle fiercely for customers


